Early-Life Screen Time Tied to Atypical Sensory Processing Outcomes in Toddlers
By Lori Solomon HealthDay Reporter
WEDNESDAY, Jan. 10, 2024 -- Early-life digital media exposure is associated with atypical sensory processing outcomes in toddlers, according to a study published online Jan. 8 in JAMA Pediatrics.
Karen Frankel Heffler, M.D., from Drexel University in Philadelphia, and colleagues examined the association between early-life digital media exposure (12, 18, and 24 months of age) and sensory processing outcomes among toddlers. The analysis included data from 1,471 participants in the National Children's Study.
The researchers found that screen exposure at 12 months of age was associated with doubled odds of being in the high category of low registration (odds ratio [OR], 2.05), while the odds of being in the low category instead of the typical category decreased for sensation seeking (OR, 0.55), sensation avoiding (OR, 0.69), and low registration (OR, 0.64). Greater screen exposure at 18 months of age was associated with an increased risk for high sensation avoiding (OR, 1.23) and low registration (OR, 1.23), while greater screen exposure at 24 months was associated with an increased risk for high sensation seeking (OR, 1.20), sensory sensitivity (OR, 1.25), and sensation avoiding (OR, 1.21).
"Further research is needed to understand why early media exposure is associated with specific sensory-related behaviors, including those seen in autism spectrum disorder, and if minimizing screen media at a young age can improve subsequent sensory-related outcomes," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-01-11 00:15
Read more
- Orexo initiates new study of OX640 in participants with allergic rhiniti
- Certain Pesticides Tied to Increased Prostate Cancer Incidence, Mortality
- Biden Administration Uses Wartime Powers to Help Restart IV Fluid Plant in North Carolina
- Complete Vaccination Coverage Down in Kindergarteners for 2023-24 School Year
- Nasal Swab Might Predict How Severe COVID Will Be
- FDA Approves Itovebi for Locally Advanced, Metastatic Breast Cancer
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions